96 related articles for article (PubMed ID: 10876704)
1. [Breast cancer in patients, 70 years or older].
Hillen HF; Hupperets PS
Ned Tijdschr Geneeskd; 2000 Jun; 144(23):1099-104. PubMed ID: 10876704
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer in elderly compared to younger patients in the Netherlands: stage at diagnosis, treatment and survival in 127,805 unselected patients.
Bastiaannet E; Liefers GJ; de Craen AJ; Kuppen PJ; van de Water W; Portielje JE; van der Geest LG; Janssen-Heijnen ML; Dekkers OM; van de Velde CJ; Westendorp RG
Breast Cancer Res Treat; 2010 Dec; 124(3):801-7. PubMed ID: 20428937
[TBL] [Abstract][Full Text] [Related]
3. Postoperative adjuvant chemotherapy followed by adjuvant tamoxifen versus nil for patients with operable breast cancer: a randomised phase III trial of the European Organisation for Research and Treatment of Cancer Breast Group.
Morales L; Canney P; Dyczka J; Rutgers E; Coleman R; Cufer T; Welnicka-Jaskiewicz M; Nortier J; Bogaerts J; Therasse P; Paridaens R; ;
Eur J Cancer; 2007 Jan; 43(2):331-40. PubMed ID: 17134892
[TBL] [Abstract][Full Text] [Related]
4. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.
Mariotto AB; Feuer EJ; Harlan LC; Abrams J
J Natl Cancer Inst Monogr; 2006; (36):7-15. PubMed ID: 17032888
[TBL] [Abstract][Full Text] [Related]
5. Tamoxifen versus control after adjuvant, risk-adapted chemotherapy in postmenopausal, receptor-negative patients with breast cancer: a randomized trial (GABG-IV D-93)--the German Adjuvant Breast Cancer Group.
Kaufmann M; Graf E; Jonat W; Eiermann W; Geberth M; Albert US; Gademann G; Conrad B; Stahl K; von Minckwitz G; Schumacher M;
J Clin Oncol; 2005 Nov; 23(31):7842-8. PubMed ID: 16258087
[TBL] [Abstract][Full Text] [Related]
6. Radiation therapy plus tamoxifen versus tamoxifen alone after breast-conserving surgery in postmenopausal women with stage I breast cancer: a decision analysis.
Punglia RS; Kuntz KM; Lee JH; Recht A
J Clin Oncol; 2003 Jun; 21(12):2260-7. PubMed ID: 12805324
[TBL] [Abstract][Full Text] [Related]
7. Advanced age and adjuvant tamoxifen prescription in early-stage breast carcinoma patients.
Blackman SB; Lash TL; Fink AK; Ganz PA; Silliman RA
Cancer; 2002 Dec; 95(12):2465-72. PubMed ID: 12467058
[TBL] [Abstract][Full Text] [Related]
8. Co-expression of estrogen receptor alpha and Apolipoprotein D in node positive operable breast cancer--possible relevance for survival and effects of adjuvant tamoxifen in postmenopausal patients.
Søiland H; Skaland I; Varhaug JE; Kørner H; Janssen EA; Gudlaugsson E; Baak JP; Søreide JA
Acta Oncol; 2009; 48(4):514-21. PubMed ID: 19107621
[TBL] [Abstract][Full Text] [Related]
9. Improved survival for women with stage I breast cancer in south-east Sweden: a comparison between two time periods before and after increased use of adjuvant systemic therapy.
Johansson P; Fohlin H; Arnesson LG; Dufmats M; Nordenskjöld K; Nordenskjöld B; Stål O;
Acta Oncol; 2009; 48(4):504-13. PubMed ID: 19235568
[TBL] [Abstract][Full Text] [Related]
10. DNA-methylation of the homeodomain transcription factor PITX2 reliably predicts risk of distant disease recurrence in tamoxifen-treated, node-negative breast cancer patients--Technical and clinical validation in a multi-centre setting in collaboration with the European Organisation for Research and Treatment of Cancer (EORTC) PathoBiology group.
Maier S; Nimmrich I; Koenig T; Eppenberger-Castori S; Bohlmann I; Paradiso A; Spyratos F; Thomssen C; Mueller V; Nährig J; Schittulli F; Kates R; Lesche R; Schwope I; Kluth A; Marx A; Martens JW; Foekens JA; Schmitt M; Harbeck N;
Eur J Cancer; 2007 Jul; 43(11):1679-86. PubMed ID: 17601725
[TBL] [Abstract][Full Text] [Related]
11. [Trends in breast cancer treatment in the elderly at a breast cancer outpatient clinic: guidelines followed better].
Hamaker ME; Schreurs WH; van Slooten HJ; Uppelschoten JM; Smorenburg CH
Ned Tijdschr Geneeskd; 2009; 153():A562. PubMed ID: 19930741
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of tumour-specific HMG-CoA reductase expression in primary breast cancer.
Borgquist S; Jögi A; Pontén F; Rydén L; Brennan DJ; Jirström K
Breast Cancer Res; 2008; 10(5):R79. PubMed ID: 18808688
[TBL] [Abstract][Full Text] [Related]
13. Current controversies in extended adjuvant endocrine therapy for early breast cancer.
Snoj N; Paridaens R; Cufer T
Curr Opin Oncol; 2008 Nov; 20(6):627-33. PubMed ID: 18841043
[TBL] [Abstract][Full Text] [Related]
14. Physicians' assessments of adjuvant tamoxifen's effectiveness in older patients with primary breast cancer.
Lash TL; Gurwitz JH; Silliman RA
J Am Geriatr Soc; 2005 Nov; 53(11):1889-96. PubMed ID: 16274369
[TBL] [Abstract][Full Text] [Related]
15. Poor outcome of hormone receptor-positive breast cancer at very young age is due to tamoxifen resistance: nationwide survival data in Korea--a report from the Korean Breast Cancer Society.
Ahn SH; Son BH; Kim SW; Kim SI; Jeong J; Ko SS; Han W;
J Clin Oncol; 2007 Jun; 25(17):2360-8. PubMed ID: 17515570
[TBL] [Abstract][Full Text] [Related]
16. Comorbidity in older surgical cancer patients: influence on patient care and outcome.
Janssen-Heijnen ML; Maas HA; Houterman S; Lemmens VE; Rutten HJ; Coebergh JW
Eur J Cancer; 2007 Oct; 43(15):2179-93. PubMed ID: 17681780
[TBL] [Abstract][Full Text] [Related]
17. [Effective treatment strategy in elderly breast cancer patients].
Boér K
Orv Hetil; 2005 Jan; 146(1):15-21. PubMed ID: 15715368
[TBL] [Abstract][Full Text] [Related]
18. [Medical treatment for older breast cancer patients].
Osaki A; Saeki T
Gan To Kagaku Ryoho; 2007 Mar; 34(3):374-9. PubMed ID: 17353627
[TBL] [Abstract][Full Text] [Related]
19. 16. Breast cancer in older women.
Bultitude MF; Fentiman IS
Int J Clin Pract; 2002 Oct; 56(8):588-90. PubMed ID: 12425368
[TBL] [Abstract][Full Text] [Related]
20. Benefit and projected cost-effectiveness of anastrozole versus tamoxifen as initial adjuvant therapy for patients with early-stage estrogen receptor-positive breast cancer.
Hillner BE
Cancer; 2004 Sep; 101(6):1311-22. PubMed ID: 15368322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
